| Primary |
| Ill-defined Disorder |
21.8% |
| Back Pain |
16.9% |
| Pain |
14.5% |
| Fibromyalgia |
8.9% |
| Muscle Spasms |
6.5% |
| Anxiety |
3.2% |
| Depression |
3.2% |
| Insomnia |
3.2% |
| Migraine |
2.4% |
| Myalgia |
2.4% |
| Neck Pain |
2.4% |
| Non-small Cell Lung Cancer |
2.4% |
| Breast Cancer |
1.6% |
| Convulsion |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Hepatitis C |
1.6% |
| Multiple Sclerosis |
1.6% |
| Muscle Relaxant Therapy |
1.6% |
| Rheumatoid Arthritis |
1.6% |
| Abdominal Pain |
0.8% |
|
| Vomiting |
11.9% |
| Acute Hepatic Failure |
10.2% |
| Overdose |
8.5% |
| Convulsion |
6.8% |
| Drug Abuse |
6.8% |
| Depression |
5.1% |
| Drug Withdrawal Syndrome |
5.1% |
| Unresponsive To Stimuli |
5.1% |
| Anaphylactic Reaction |
3.4% |
| Hepatitis C |
3.4% |
| Hepatotoxicity |
3.4% |
| Loss Of Consciousness |
3.4% |
| Muscle Rigidity |
3.4% |
| Pharmaceutical Product Complaint |
3.4% |
| Somnolence |
3.4% |
| Speech Disorder |
3.4% |
| Subdural Haematoma |
3.4% |
| Suicidal Ideation |
3.4% |
| Toxicity To Various Agents |
3.4% |
| Treatment Noncompliance |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
30.9% |
| Pain |
13.7% |
| Drug Use For Unknown Indication |
12.5% |
| Foetal Exposure During Pregnancy |
5.8% |
| Back Pain |
3.9% |
| Depression |
3.5% |
| Anxiety |
3.3% |
| Rheumatoid Arthritis |
3.1% |
| Fibromyalgia |
3.0% |
| Muscle Spasms |
3.0% |
| Insomnia |
2.9% |
| Neck Pain |
2.7% |
| Migraine |
2.4% |
| Hypertension |
1.7% |
| Muscle Relaxant Therapy |
1.7% |
| Headache |
1.4% |
| Intervertebral Disc Degeneration |
1.2% |
| Neuropathy Peripheral |
1.2% |
| Drug Abuse |
1.0% |
| Gastrooesophageal Reflux Disease |
0.8% |
|
| Drug Hypersensitivity |
9.6% |
| Somnolence |
7.8% |
| Vomiting |
7.2% |
| Treatment Noncompliance |
6.6% |
| Death |
5.4% |
| Drug Toxicity |
5.4% |
| Suicidal Ideation |
5.4% |
| Toxicity To Various Agents |
5.4% |
| Unresponsive To Stimuli |
5.4% |
| Drug Abuse |
4.8% |
| Overdose |
4.8% |
| Convulsion |
4.2% |
| Tremor |
4.2% |
| Loss Of Consciousness |
3.6% |
| Psychotic Disorder |
3.6% |
| Suicide Attempt |
3.6% |
| Weight Increased |
3.6% |
| Drug Dependence |
3.0% |
| Hypertension |
3.0% |
| Maternal Exposure During Pregnancy |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.3% |
| Pain |
15.1% |
| Drug Use For Unknown Indication |
8.7% |
| Back Pain |
5.8% |
| Depression |
5.6% |
| Anxiety |
4.7% |
| Muscle Spasms |
4.2% |
| Fibromyalgia |
3.9% |
| Hypertension |
3.8% |
| Rheumatoid Arthritis |
3.4% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Insomnia |
3.1% |
| Sleep Disorder |
2.9% |
| Smoking Cessation Therapy |
2.8% |
| Muscle Relaxant Therapy |
2.3% |
| Migraine |
2.0% |
| Osteoporosis |
2.0% |
| Asthma |
1.9% |
| Bipolar Disorder |
1.8% |
| Multiple Sclerosis |
1.7% |
|
| Weight Increased |
13.4% |
| Vomiting |
13.0% |
| Weight Decreased |
12.7% |
| Wrong Technique In Drug Usage Process |
8.6% |
| Pain |
6.0% |
| Drug Ineffective |
4.9% |
| Nausea |
4.6% |
| Vision Blurred |
3.7% |
| Suicidal Ideation |
3.6% |
| Somnolence |
3.4% |
| Withdrawal Syndrome |
3.3% |
| Tremor |
3.2% |
| Type 2 Diabetes Mellitus |
2.8% |
| Suicide Attempt |
2.7% |
| Headache |
2.6% |
| Rash |
2.4% |
| Pain In Extremity |
2.4% |
| Pulmonary Embolism |
2.3% |
| Off Label Use |
2.2% |
| Pneumonia |
2.2% |
|
| Interacting |
| Pain |
41.9% |
| Analgesic Therapy |
6.5% |
| Drug Use For Unknown Indication |
6.5% |
| Fibromyalgia |
6.5% |
| Hypertension |
6.5% |
| Insomnia |
6.5% |
| Muscle Spasms |
6.5% |
| Back Pain |
3.2% |
| Intervertebral Disc Protrusion |
3.2% |
| Muscle Relaxant Therapy |
3.2% |
| Pain In Extremity |
3.2% |
| Product Used For Unknown Indication |
3.2% |
| Smoking Cessation Therapy |
3.2% |
|
| Drug Interaction |
33.3% |
| Grand Mal Convulsion |
16.7% |
| Somnambulism |
16.7% |
| Drug Ineffective |
8.3% |
| Product Quality Issue |
8.3% |
| Somnolence |
8.3% |
| Treatment Noncompliance |
8.3% |
|
